Archives: Speakers

Results-oriented Professional in Medical Device & Pharmaceutical industries with experience in ERP, Lean-Six Sigma, Configuration Specification and Integration Testing, Investigations (CAPA System), Complaints Investigations and Management, Regulatory Agency Audits, Technology Transfer and Startups, Design Controls, Customer Field Support, Operations and Validation focusing on compliance withwith FDA and International regulations and voluntary standards in an environment of continuous improvement and safety.

Risk Management Executive with over twenty-five years of financial services experience, delivering risk management solutions within banking and insurance industries across a variety of global jurisdictions.With experience of strategic transformation, risk framework development and implementation and regulatory interventions. Operating at the forefront of risk management developments from a regulatory and business perspective. Experience of Regulatory policy making with the Financial Services Authority during Basel II and with KPMG during the development of Solvency II.

Paul Swinckels is the Chief Commercial Officer (CCO) at LifeSense Group who has more than 20 years of experience in Electronic devices and since 2017 in the wearable medical devices technology. Paul knows how to bring added value to the customers and bring the needs into the right solution for the end user. Paul worked for 17 years in the high-end technology segment at GE in Western Europe which was acquired in by United Technologies later. With the experience of and partnering with private and government hospitals, clinics, Doctors and multi nationals, he provides the right solution for the real needs of the patients.

Serpil Tutan is a Director of Clinical Research at the Research Resources Office, Baylor College of Medicine/Texas Children’s Hospital. She has more than 24 years of nursing and clinical research experience. Some of her current responsibilities include, protocol development, feasibility reviews, budget negotiations, and direct oversight of the clinical trial finance, regulatory and QA/QC teams. She had successfully completed institutional launch of the Clinical Trial Management System, financial module at Texas Children’s Hospital. One of her passions is protocol development and project management for all aspects of investigator initiated and/or rare disease trials.

Since 2010 Nyasha has led initiatives in insurance businesses to understand new geographic markets, customer cohorts and emerging trends, develop strategies to take advantage of the opportunity, implement new products and services, and launch them. A large part of Nyasha career has been orientated towards and has developed a passions for Digital and emerging technology trends Small businesses and start-ups